In today's ACT Brief, we explore how continuous remote monitoring enables early clinical interventions, FDA guidance on validating new approach methodologies as alternatives to animal testing, and the ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
AI-based approaches are increasingly capturing complex human disease biology directly, without the use of potentially confounding animal models. [ignatiev / Getty Images] The recent decision by the ...
Well before a human receives the first dose of an experimental drug, it’s evaluated in an animal to test for toxicity. Monkeys are often chosen for their genetic similarities to humans, and safe ...
Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies ...
The US Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results